dc.contributor.author | Zhao, Liqin | |
dc.contributor.author | Mao, Zisu | |
dc.contributor.author | Brinton, Roberta Diaz | |
dc.date.accessioned | 2015-05-13T17:32:11Z | |
dc.date.available | 2015-05-13T17:32:11Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Zhao, Liqin, Zisu Mao and Roberta Diaz Brinton. "A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor β-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo." Endocrinology, February 2009, 150(2):770–783. http://dx.doi.org/10.1210/en.2008-0715 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/17753 | |
dc.description.abstract | We have previously shown that a number of naturally occurring phytoestrogens and derivatives were effective to induce some measures of neuroprotective responses but at a much lower magnitude than those induced by the female gonadal estrogen 17β-estradiol. In the present study, we sought to investigate whether a combination of select phytoestrogens could enhance neural responses without affecting the reproductive system. We performed a range of comparative analyses of the estrogen receptor (ER) α/β binding profile, and in vitro to in vivo estrogenic activities in neural and uterine tissues induced by clinically relevant phytoestrogens: genistein, daidzein, equol, and IBSO03569, when used alone or in combination. Our analyses revealed that both the ERα/β binding profile and neural activities associated with individual phytoestrogens are modifiable when used in combination. Specifically, the combination of genistein plus daidzein plus equol resulted in the greatest binding selectivity for ERβ and an overall improved efficacy/safety profile when compared with single or other combined formulations, including: 1) an approximate 30% increase in ERβ-binding selectivity (83-fold over ERα); 2) a greater effect on neuronal survival against toxic insults in primary neurons; 3) an enhanced activity in promoting neural proactive defense mechanisms against neurodegeneration, including mitochondrial function and β-amyloid degradation; and 4) no effect on uterine growth. These observations suggest that select phytoestrogens in combination have the therapeutic potential of an alternative approach to conventional estrogen therapy for long-term safe use to reduce the increased risk of cognitive decline and neurodegenerative disease associated with menopause in women.A combination of genistein, daidzein, and equol enhances estrogen receptor β-binding selectivity and estrogenic activities in promoting neuronal survival and brain defense mechanisms without impact on uterine growth. | en_US |
dc.description.sponsorship | This work was supported by grants from the Alzheimer’s Association (to L.Z.), Kenneth T. and Eileen L. Norris Foundation, and Bensussen Translational Research Fund (to R.D.B.). | en_US |
dc.publisher | Endocrine Society | en_US |
dc.title | A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor β-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo | en_US |
dc.type | Article | |
kusw.kuauthor | Zhao, Liqin | |
kusw.kudepartment | Department of Pharmaceutical Chemistry | en_US |
dc.identifier.doi | 10.1210/en.2008-0715 | |
kusw.oaversion | Scholarly/refereed, publisher version | |
kusw.oapolicy | This item does not meet KU Open Access policy criteria. | |
dc.rights.accessrights | openAccess | |